Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave.
Vos ERA, den Hartog G, Schepp RM, Kaaijk P, van Vliet J, Helm K, Smits G, Wijmenga-Monsuur A, Verberk JDM, van Boven M, van Binnendijk RS, de Melker HE, Mollema L, van der Klis FRM. Vos ERA, et al. J Epidemiol Community Health. 2020 Nov 28;75(6):489-95. doi: 10.1136/jech-2020-215678. Online ahead of print. J Epidemiol Community Health. 2020. PMID: 33249407 Free PMC article.
Persistence of Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 in Relation to Symptoms in a Nationwide Prospective Study.
den Hartog G, Vos ERA, van den Hoogen LL, van Boven M, Schepp RM, Smits G, van Vliet J, Woudstra L, Wijmenga-Monsuur AJ, van Hagen CCE, Sanders EAM, de Melker HE, van der Klis FRM, van Binnendijk RS. den Hartog G, et al. Among authors: vos era. Clin Infect Dis. 2021 Dec 16;73(12):2155-2162. doi: 10.1093/cid/ciab172. Clin Infect Dis. 2021. PMID: 33624751 Free PMC article.
Associations Between Measures of Social Distancing and Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity: A Nationwide Population-based Study in the Netherlands.
Vos ERA, van Boven M, den Hartog G, Backer JA, Klinkenberg D, van Hagen CCE, Boshuizen H, van Binnendijk RS, Mollema L, van der Klis FRM, de Melker HE. Vos ERA, et al. Clin Infect Dis. 2021 Dec 16;73(12):2318-2321. doi: 10.1093/cid/ciab264. Clin Infect Dis. 2021. PMID: 33772265 Free PMC article.
Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands.
McDonald SA, Miura F, Vos ERA, van Boven M, de Melker HE, van der Klis FRM, van Binnendijk RS, den Hartog G, Wallinga J. McDonald SA, et al. Among authors: vos era. Eur J Epidemiol. 2021 Jul;36(7):735-739. doi: 10.1007/s10654-021-00768-y. Epub 2021 Jun 10. Eur J Epidemiol. 2021. PMID: 34114187 Free PMC article.
Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021.
de Gier B, Andeweg S, Joosten R, Ter Schegget R, Smorenburg N, van de Kassteele J; RIVM COVID-19 surveillance and epidemiology team 1,; Hahné SJ, van den Hof S, de Melker HE, Knol MJ; Members of the RIVM COVID-19 surveillance and epidemiology team. de Gier B, et al. Euro Surveill. 2021 Aug;26(31):2100640. doi: 10.2807/1560-7917.ES.2021.26.31.2100640. Euro Surveill. 2021. PMID: 34355689 Free PMC article.
Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021.
de Gier B, Andeweg S, Backer JA; RIVM COVID-19 surveillance and epidemiology team; Hahné SJ, van den Hof S, de Melker HE, Knol MJ; RIVM COVID-19 surveillance and epidemiology team (in addition to the named authors). de Gier B, et al. Euro Surveill. 2021 Nov;26(44):2100977. doi: 10.2807/1560-7917.ES.2021.26.44.2100977. Euro Surveill. 2021. PMID: 34738514 Free PMC article.
Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?
van den Hoogen LL, Smits G, van Hagen CCE, Wong D, Vos ERA, van Boven M, de Melker HE, van Vliet J, Kuijer M, Woudstra L, Wijmenga-Monsuur AJ, GeurtsvanKessel CH, Stoof SP, Reukers D, Wijsman LA, Meijer A, Reusken CBEM, Rots NY, van der Klis FRM, van Binnendijk RS, den Hartog G. van den Hoogen LL, et al. Among authors: vos era. Vaccine. 2022 Apr 1;40(15):2251-2257. doi: 10.1016/j.vaccine.2022.03.009. Epub 2022 Mar 9. Vaccine. 2022. PMID: 35287986 Free PMC article.
18 results